220 related articles for article (PubMed ID: 16837029)
41. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
42. Endoplasmic reticulum stress is activated in endometrial adenocarcinoma.
Bifulco G; Miele C; Di Jeso B; Beguinot F; Nappi C; Di Carlo C; Capuozzo S; Terrazzano G; Insabato L; Ulianich L
Gynecol Oncol; 2012 Apr; 125(1):220-5. PubMed ID: 22146569
[TBL] [Abstract][Full Text] [Related]
43. Loss of RKIP expression during the carcinogenic evolution of endometrial cancer.
Martinho O; Faloppa CC; Neto CS; Longatto-Filho A; Baiocchi G; da Cunha IW; Soares FA; Fregnani JH; Reis RM
J Clin Pathol; 2012 Feb; 65(2):122-8. PubMed ID: 22031589
[TBL] [Abstract][Full Text] [Related]
44. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
Giatromanolaki A; Sivridis E; Koukourakis MI; Georgoulias V; Gatter KC; Harris AL
Oncol Res; 1999; 11(4):205-12. PubMed ID: 10566619
[TBL] [Abstract][Full Text] [Related]
45. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
46. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
47. Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades.
Evans JJ; Chitcholtan K; Dann JM; Guilford P; Harris G; Lewis LK; Nagase J; Welkamp AA; Zwerus R; Sykes PH
Gynecol Oncol; 2012 Apr; 125(1):214-9. PubMed ID: 22178239
[TBL] [Abstract][Full Text] [Related]
48. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.
Xia G; Kumar SR; Hawes D; Cai J; Hassanieh L; Groshen S; Zhu S; Masood R; Quinn DI; Broek D; Stein JP; Gill PS
J Urol; 2006 Apr; 175(4):1245-52. PubMed ID: 16515971
[TBL] [Abstract][Full Text] [Related]
49. The expression of vascular endothelial growth factor and its receptors (flt1/fms, flk1/KDR, flt4) and vascular endothelial growth inhibitor in the bovine uterus during the sexual cycle and their correlation with serum sex steroids.
Sağsöz H; Saruhan BG
Theriogenology; 2011 Jun; 75(9):1720-34. PubMed ID: 21396695
[TBL] [Abstract][Full Text] [Related]
50. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
51. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract][Full Text] [Related]
52. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
Bhattacharya R; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
[TBL] [Abstract][Full Text] [Related]
53. Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.
Wang J; Taylor A; Showeil R; Trivedi P; Horimoto Y; Bagwan I; Ewington L; Lam EW; El-Bahrawy MA
Cytokine; 2014 Aug; 68(2):94-100. PubMed ID: 24845798
[TBL] [Abstract][Full Text] [Related]
54. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
Koukourakis MI; Giatromanolaki A; Simopoulos C; Polychronidis A; Sivridis E
Clin Exp Metastasis; 2005; 22(1):25-30. PubMed ID: 16132575
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
[TBL] [Abstract][Full Text] [Related]
56. Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients.
Azuma M; Shi M; Danenberg KD; Gardner H; Barrett C; Jacques CJ; Sherod A; Iqbal S; El-Khoueiry A; Yang D; Zhang W; Danenberg PV; Lenz HJ
Pharmacogenomics; 2007 Dec; 8(12):1705-13. PubMed ID: 18086000
[TBL] [Abstract][Full Text] [Related]
57. Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
Giatromanolaki A; Sivridis E; Bechrakis NE; Willerding G; St Charitoudis G; Foerster MH; Gatter KC; Harris AL; Koukourakis MI
Clin Exp Metastasis; 2012 Jan; 29(1):11-7. PubMed ID: 21984395
[TBL] [Abstract][Full Text] [Related]
58. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
Koukourakis MI; Giatromanolaki A; Sivridis E; Bougioukas G; Didilis V; Gatter KC; Harris AL;
Br J Cancer; 2003 Sep; 89(5):877-85. PubMed ID: 12942121
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.
Koukourakis MI; Kakouratos C; Kalamida D; Bampali Z; Mavropoulou S; Sivridis E; Giatromanolaki A
Int J Radiat Biol; 2016 Jul; 92(7):353-63. PubMed ID: 27010533
[TBL] [Abstract][Full Text] [Related]
60. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
Koukourakis MI; Giatromanolaki A; Polychronidis A; Simopoulos C; Gatter KC; Harris AL; Sivridis E
Cancer Sci; 2006 Jul; 97(7):582-8. PubMed ID: 16827797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
